Group 1 - The A-share market shows a strong growth style, with notable performances in the pharmaceutical and semiconductor sectors, where multiple related ETFs rose over 5% in a single day [1] - The Hong Kong pharmaceutical sector is performing strongly, with several ETFs in this category, including the Hong Kong Medical ETF, rising over 6% [4][5] - The semiconductor sector is also experiencing significant gains, with multiple ETFs in this field increasing by over 5% [6][7] Group 2 - In December 2025, the A500 and Sci-Tech bonds became major directions for capital inflow, with several related ETFs seeing net inflows exceeding 100 billion yuan [2][8] - The total net inflow for all ETFs in the market reached 11,785.99 billion yuan in 2025 [2] - Four ETFs had net inflows exceeding 400 billion yuan in 2025, indicating strong investor interest [10][11] Group 3 - The Hong Kong market is expected to see a recovery in corporate earnings, with sectors benefiting from overseas demand and competitive industry leaders likely to experience greater profit elasticity [12] - The liquidity in the Hong Kong market is anticipated to improve, potentially leading to valuation increases, especially if the Federal Reserve lowers interest rates [12]
ETF龙虎榜 | 万亿资金 涌入！
Zhong Guo Zheng Quan Bao·2026-01-05 15:17